BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21921088)

  • 1. A systematic review of endoglin gene expression in preeclampsia.
    Bell MJ; Conley YP
    Biol Res Nurs; 2013 Apr; 15(2):129-36. PubMed ID: 21921088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in endoglin pathway genes is associated with preeclampsia: a case-control candidate gene association study.
    Bell MJ; Roberts JM; Founds SA; Jeyabalan A; Terhorst L; Conley YP
    BMC Pregnancy Childbirth; 2013 Apr; 13():82. PubMed ID: 23548068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia.
    Farina A; Sekizawa A; De Sanctis P; Purwosunu Y; Okai T; Cha DH; Kang JH; Vicenzi C; Tempesta A; Wibowo N; Valvassori L; Rizzo N
    Prenat Diagn; 2008 Oct; 28(10):956-61. PubMed ID: 18792924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies.
    Toft JH; Lian IA; Tarca AL; Erez O; Espinoza J; Eide IP; Bjørge L; Draghici S; Romero R; Austgulen R
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):267-73. PubMed ID: 18330824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: A systematic review and meta-analysis.
    Margioula-Siarkou G; Margioula-Siarkou C; Petousis S; Margaritis K; Alexandratou M; Dinas K; Sotiriadis A; Mavromatidis G
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():366-381. PubMed ID: 33529972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women.
    Purwosunu Y; Sekizawa A; Yoshimura S; Farina A; Wibowo N; Nakamura M; Shimizu H; Okai T
    Reprod Sci; 2009 Sep; 16(9):857-64. PubMed ID: 19474289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera.
    Aoki Y; Yamamoto T; Fumihisa C; Nakamura A; Asanuma A; Suzuki M
    Am J Reprod Immunol; 2012 May; 67(5):413-20. PubMed ID: 22040284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country.
    Reyes LM; García RG; Ruiz SL; Broadhurst D; Aroca G; Davidge ST; López-Jaramillo P
    Growth Factors; 2012 Jun; 30(3):158-66. PubMed ID: 22486210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane and soluble forms of endoglin in preeclampsia.
    Oujo B; Perez-Barriocanal F; Bernabeu C; Lopez-Novoa JM
    Curr Mol Med; 2013 Sep; 13(8):1345-57. PubMed ID: 23826920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
    Gu Y; Lewis DF; Wang Y
    J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women.
    ElMonier AA; El-Boghdady NA; Abdelaziz MA; Shaheen AA
    Arch Biochem Biophys; 2019 Feb; 662():7-14. PubMed ID: 30496724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia.
    Cox B; Sharma P; Evangelou AI; Whiteley K; Ignatchenko V; Ignatchenko A; Baczyk D; Czikk M; Kingdom J; Rossant J; Gramolini AO; Adamson SL; Kislinger T
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.012526. PubMed ID: 21986993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies isolated from patients with preeclampsia induce soluble endoglin production from trophoblast cells via interactions with angiotensin II type 1 receptor.
    Kobayashi Y; Yamamoto T; Chishima F; Takahashi H; Suzuki M
    Am J Reprod Immunol; 2015 Apr; 73(4):285-91. PubMed ID: 25376533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulated miR-149-5p contributes to preeclampsia via modulating endoglin expression.
    Xiaobo 赵肖波 Z; Qizhi H; Zhiping W; Tao D
    Pregnancy Hypertens; 2019 Jan; 15():201-208. PubMed ID: 30713088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoglin pathway genetic variation in preeclampsia: A validation study in Norwegian and Latina cohorts.
    Schmella MJ; Roberts JM; Conley YP; Ren D; Storvold GL; Ingles SA; Wilson ML; Staff AC; Hubel CA
    Pregnancy Hypertens; 2018 Apr; 12():144-149. PubMed ID: 29580923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of Vegfr-2 and its soluble form in preeclampsia.
    Munaut C; Lorquet S; Pequeux C; Coulon C; Le Goarant J; Chantraine F; Noël A; Goffin F; Tsatsaris V; Subtil D; Foidart JM
    PLoS One; 2012; 7(3):e33475. PubMed ID: 22428059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia.
    López-Novoa JM
    Nephrol Dial Transplant; 2007 Mar; 22(3):712-4. PubMed ID: 17210583
    [No Abstract]   [Full Text] [Related]  

  • 20. Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia.
    Zhang YG; Yang HL; Long Y; Li WL
    BJOG; 2016 Dec; 123(13):2113-2118. PubMed ID: 26846540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.